Welcome : Guest

Qiagen N.V. (The Netherlands) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Qiagen N.V., which is principally involved in providing Sample and Assay Technologies. Illustrated with 82 tables, the report showcases the company's sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-02757
Price: $3500
Company Type: Public
Pages: 87
Date: November 2016
Market Data Tables: 82

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Qiagen N.V.'s Sales by Product Category Worldwide (2014-2015) in Percentage for Consumables and Related Revenues, and Instrumentation......3
Table 2: Qiagen N.V.'s Sales by Geographic Region Worldwide (2014-2015) in Percentage for Americas, Europe, Middle East and Africa, and Asia-Pacific & Rest of World......4
Diagnostic Testing......8
Table 3: Diagnostics Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Hospitals, Independent Labs, Physician Office Labs and Others......8
Table 4: Diagnostics Market by Segment Worldwide (2015) - Percentage Share Breakdown by Volume Sales for Hospitals, Independent Labs, Physician Office Labs and Others......9
Table 5: Diagnostics Tests Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for BSI Gram-Negative, BSI Gram-Positive, Clostridium Difficile, Enteric, and Respiratory Virus......10
Table 6: Diagnostics Tests Market by Type in the US (2015) - Percentage Share Breakdown by Value for BSI Gram-Negative, BSI Gram-Positive, Clostridium Difficile, Enteric, and Respiratory Virus......11
Table 7: Diagnostic Test Sales by Category in the US (2015) - Percentage Market Share Breakdown by No. of Solid Tumour Patients for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......12
Table 8: Diagnostic Testing Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Ambulatory Physician Services, and Hospital Services......13
Table 9: Diagnostic Testing Market by Segment in the US (2015) - Percentage Share Breakdown by Value Sales for Hospital Outreach, Independent Labs, Inpatient, Outpatient, POLs, and Others......14
Table 10: Diagnostic Testing Sales by Category in the US (2015) - Percentage Share Breakdown by Value for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......15
DNA Carrier Testing......16
Table 11: DNA Carrier Testing Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......16
DNA & Gene Chips (Microarray)......17
Table 12: Global DNA & Gene Chip (Microarray) Market (2012-2017) in US$ Million......17
Table 13: Global Top 3 DNA Genotyping Microarray Vendors Market Share (2014) by Revenue for Illumina Inc., Affymetrix Inc., Sequenom Inc., and Others......18
Table 14: DNA Microarrays Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Cytogenetics, Expression, Genotyping, and Others......19
Genetic Testing......20
Table 15: Genetic Test Market by Segment in the US (2015) - Percentage Share Breakdown by Volume for Exome, Mendeliome, Small Panel, and Whole Genome......20
Table 16: Genetic Testing Market by Category in the US (2015) - Percentage Share Breakdown by Volume for Cancer, Neurology, Pediatric Development, and Others......21
Table 17: Genetic Testing Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Detection, Predisposition, Treatment Selection, Monitoring, and Others......22
Molecular Diagnostics......23
Table 18: Molecular Diagnostics Market by Application Worldwide (2015) - Percentage Share Breakdown by Value for Blood Screening, Genetics, Infectious Disease, Oncology and Others......23
Table 19: Global Molecular Diagnostics (MDx) Market by Infectious Diseases Therapeutic Area (2015) - Percentage Share Breakdown by Value Sales for CT/NG, Healthcare-associated Infections (HAI), Hepatitis, HIV, Respiratory and Others......24
Table 20: Global Molecular Diagnostics (MDx) Market by Region (2015) - Percentage Breakdown by Value Sales for Americas, EMEA and Pacific......25
Table 21: Molecular Diagnostic Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Disease Inherited, Infectious Diseases, Oncology, Prenatal, and Tissue Typing......26
Table 22: Molecular Diagnostics (MDx) Market by Location of Test Worldwide (2015) - Percentage Share Breakdown by Value Sales for Blood Banks, Hospitals, Near-Patient, and Reference Labs......27
Table 23: Molecular Diagnostics (MDx) Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Bacteriology, Blood Screening, Genomics and Virology......28
Table 24: Molecular Diagnostics (MDx) Market by Technology Worldwide (2015) - Percentage Share Breakdown by Value Sales for Beads, CE Sequencing, Hybrid Capture, ISH, Microarrays, NGS, PCR, Qpcr, TMA, and Others......29
Table 25: Molecular Diagnostics (MDx) Market by Therapeutic Area Worldwide (2015) - Percentage Share Breakdown by Value Sales for Blood Screening, CT / NG, HAIs, HLA, HPV, Oncology, Viral Load, and Others......30
Table 26: Molecular Diagnostics (MoDx) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for Europe, Japan, Korea, US, and Others......31
Table 27: Molecular Diagnostics Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Biochip and Lab-on-a-Chip (LOAC), In Situ Hybridization (ISH), Microarrays, Polymerase Chain Reaction (PCR) and Others......32
Table 28: Molecular Diagnostics Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Infectious Diseases, Inherited Disease, Oncology, Prenatal and Tissue Typing......33
Table 29: Molecular Diagnostics Infectious Diseases Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Active Tuberculosis, Blood Banking, Chlamydia trachomatis (CT), and Neisseria gonorrhoeae (NG), Clostridium difficile, Human Papillomavirus (HPV), Influenza, Panels, S. aureus (SA), and methicillin-resistant S. aureus (MRSA), Viral Load, and Others......34
Table 30: Molecular Diagnostics Test Market by Type in Europe (2015) - Percentage Share Breakdown by Volume for Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG), Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV), Methicillin-resistant Staphylococcus aureus (MRSA) and Others......35
Table 31: Spending on Molecular Diagnostics and Genetic Testing by Payer in the US (2015) - Percentage Market Share Breakdown by Value for Cancer, Infectious Diseases, Inhired Conditions and Others......36
Table 32: Molecular Diagnostics Lab Market by Test Complexity in the US (2015) - Percentage Share Breakdown by Volume for Highly Complex w/LDT, Highly Complex, no LDT and Moderately Complex......37
Table 33: Molecular Diagnostics Lab Market by Test Type in the US (2015) - Percentage Share Breakdown by Volume for Both ID & Genetics, Disease, Only and Infectious......38
Table 34: Molecular Diagnostics Market by Segment in the US (2015) - Percentage Share Breakdown by Value Sales for Blood Screening, Genetic Testing Order, Oncology, Virology and Other Infectious Diseases......39
Table 35: Molecular Diagnostic Genetics Laboratories Market by Assay in the US (2015) - Percentage Share Breakdown by Value Sales for Cystic Fibrosis, Epidermal Growth Factor Receptor (EGFR), Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS Gene) and Others......40
Table 36: Number of Molecular Diagnostics Laboratories by CLIA Complexity in the US (2015) - Percentage Market Share Breakdown for Highly Complex, No Laboratory-Developed Test (LDT), Highly Complex, With Laboratory-Developed Test (LDT) and Moderately Complex......41
Table 37: Number of Molecular Diagnostics Laboratories by Testing Type in the US (2015) - Percentage Market Share Breakdown for Genetics Only, Infectious Disease Only and Both Infectious Disease and Genetics......42
Molecular Cystic Fibrosis (CF) Testing......43
Table 38: Molecular Cystic Fibrosis (CF) Testing Market by Assay in the US (2015) - Percentage Share Breakdown by Value Sales for Cystic Fibrosis Genotyping, eSensor® Cystic Fibrosis, InPlex® Cystic Fibrosis (CF), Laboratory Developed Tests and xTAG® Cystic Fibrosis......43
Molecular Infectious Disease Testing......44
Table 39: Molecular Infectious Disease Market by Panel Worldwide (2015) - Percentage Share Breakdown by Value Sales for BSI +/- (Sepsis), CSF, Enteric (GI), Fungal (Candida), HCV Genotyping, Respiratory, and STI......44
Table 40: Molecular Infectious Disease Diagnostic Equipment Market by Platform Worldwide (2015) - Percentage Share Breakdown by Value Sales for BioFire, LX 100/200 & MAGPIX, MALDI Biotyper, Verigene, XT-8, and Others......45
Molecular Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing......46
Table 41: Molecular Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market by Type in the US (2015) - Percentage Share Breakdown by Value Sales for Chromogenic Media, Conventional Media, GeneXpert, GneOhm, LightCycler and Molecular Diagnostics Laboratory-Developed Test (MDX LDT)......46
Cancer Drugs......47
Table 42: Oncology/Hematology Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Blood Cell Factors, Chemopreventatives, Chemotherapeutics, Mabs, Targeted Therapies, and Others......47
Table 43: Oncology Drug Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for European Union Five, Japan, US and Others......48
Cancer Market......49
Table 44: Cancer Care Expenditure by Site Worldwide (2015) - Percentage Share Breakdown for Breast, Colorectal, Lymphoma, Lung, Prostate and Others......49
Table 45: Cancer Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Heme, Lung, Prostate, and Others......50
Table 46: Oncology Market by Cancer Type Worldwide (2015) - Percentage Share Breakdown by Value for Breast Cancer, Metastatic Colorectal Cancer, Non-Small Cell Lung Cancer, and Others......51
Table 47: Clinical Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......52
Table 48: Hereditary Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......53
Table 49: Cancer Market by Type in China (2015) - Percentage Share Breakdown by Value for Breast, Colorectal, Esophagus, Liver, Lung, Stomach and Others......54
Table 50: Oncology Market by Category in China (2015) - Percentage Share Breakdown by Value for Anti- Tumor Agents, Hormone Therapy, Immuno Suppresants and Immunostimulants......55
Table 51: Oncology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Solid Tumor and Others......56
Infectious Disease Drugs......57
Table 52: Infectious Disease Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Molecular Diagnostics Infectious Diseases, and Others......57
Table 53: Infectious Disease Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Antifungals, Antivirals, Cephalosporins, Macrolides, Penicillins, Quinolones, and Others......58
Diagnostic Testing......59
Table 54: Market Shares of Leading Diagnostic Testing Companies in the US (2015) - Percentage Share Breakdown by Value for Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated and Others......59
Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Testing......60
Table 55: Market Shares of Leading Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Testing Providers in the US (2014) - Percentage Breakdown by Value Sales for Abbott Laboratories, Becton, Dickinson and Company, F. Hoffmann-La Roche AG, Hologic, Inc., and Qiagen NV......60
Molecular Clostridium Difficile (C. Diff) Testing......61
Table 56: Market Shares of Leading Molecular Clostridium Difficile (C. Diff) Testing Providers the US (2014) - Percentage Breakdown by Value Sales for Becton, Dickinson and Company, Cepheid, Inc., Hologic Gen-Probe, Inc., Meridian Bioscience, Inc. and Others......61
Molecular Diagnostics......62
Table 57: Market Shares of Leading Molecular Diagnostic Product Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for Abbott Laboratories, Bayer AG, Becton, Dickinson and Company, F. Hoffmann-La Roche AG, Hologic Corporation, Novartis International AG, Qiagen, and Others......62
Table 58: Market Shares of Leading Molecular Diagnostics (MDx) Companies by Value Sales Worldwide (2014) - Percentage Breakdown for Abbott Laboratories, Becton, Dickinson and Co., Cepheid, F. Hoffmann-La Roche Ltd., Hologic Gen-Probe, Inc., Novartis AG, Qiagen N.V., Siemens AG and Others......63
Table 59: Market Shares of Leading Molecular Diagnostics (MDx) Equipment Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Abbott Laboratories, Becton, Dickinson and Company, Cepheid, Inc., Hologic, Inc., Illumina, Inc., Qiagen N.V., Rogers Corporation, Siemens AG, Thermo Fisher Scientific, and Others......64
Human Papillomavirus (HPV) Testing......65
Table 60: Market Shares of Leading Human Papillomavirus (HPV) Testing Companies Worldwide (2015) - Percentage Breakdown by Value for F. Hoffmann-La Roche Ltd., Hologic, Inc., Qiagen N.V., and Others......65
Table 61: Market Shares of Leading Human Papillomavirus (HPV) Testing Companies in China (2015) - Percentage Share Breakdown by Value for Chaozhou Kaipu Biochemistry Co., Ltd., Mingyuan Medicare Development Co., Ltd., Qiagen China (Shanghai) Co., Ltd. (Digene), Yaneng Bioscience (Shenzhen) Co., Ltd., and Others......66
Molecular Human Papillomavirus (HPV) Equipment......67
Table 62: Market Shares of Leading Molecular Human Papillomavirus (HPV) Diagnostic Equipment Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for F. Hoffmann-La Roche AG, Hologic Corporation, Qiagen N.V., and Others......67
Cancer Drugs......68
Table 63: Market Shares of Leading Oncology Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Fresenius SE & Co., and Others......68
Table 64: Market Shares of Leading Oncology/Hematology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Amgen, Inc., AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......69
Table 65: Market Shares of Leading Oncology Drug Manufacturers in China (2015) - Percentage Share Breakdown by Value for Astrazeneca, Jiangsu Hengrui Medicine Co., Ltd., Roche Group and Others......70
Table 66: Anti-Cancer Drugs Market by Product Type in China (2015) - Percentage Share Breakdown by Value for Anastrozole, Capecitabine, Cetuximab, Compound kushen, Docetaxel, Epirubicin, Erlotinib, Gefitinib, Gemcitabine, Goserelin, Interferon α-2a, Interferon α-2b, Irinotecan, Kangai, Lentinan, Letrozole, Oxaliplatin, Paclitaxel, Pemetrexed, Pidotimod, RhG-CSF, RhIL-2, Rituximab, Sorafenib, Sshenqi Fuzheng, Thymopentin, Thymosin a1, Trastuzmmab, Triptorelin, TS-1, and Others......71
Table 67: Anti-Cancer Drugs Market by Type in China (2015) - Percentage Share Breakdown by Value for Alkylating Agents, Antibiotics, Antimetabolites, Hormonal Agents, Immunostimulant, Plant Alkaloids, and Others......72
Breast Cancer Drugs......73
Table 68: Market Shares of Leading Breast Cancer Drugs by Value Sales in China (2014) - Percentage Breakdown for Alkylating Agents, Antimetabolite, Antitumor Antibiotics, Antitumor Antihormone, Antitumor Botanicals, Monoclonal Antibodies, Targeted Small Molecule Agents, and Others......73
Relapsed/Refractory (RR) Chronic Lymphocytic Leukemia (CLL)......74
Table 69: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory (RR) Chronic Lymphocytic Leukemia (CLL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib, Idelalisib and Others......74
Relapsed/Refractory (RR) Indolent Non-Hodgkin's Lymphoma (iNHL)......75
Table 70: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory (RR) Indolent Non-Hodgkin's Lymphoma (iNHL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib, Idelalisib and Other......75
Table 71: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma (R/R- aNHL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib and Others......76
Neisseria Gonorrhoeae (GC)/Chalamydia Trachomatis (CT)......77
Table 72: Market Shares of Leading Neisseria Gonorrhoeae (GC)/Chalamydia Trachomatis (CT) Testing Equipment Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Becton, Dickinson and Company (BDX), Cepheid, Inc. (CPHD), F.Hoffmann-La Roche AG, Hologic, Inc. (HOLX), Qiagen N.V. (QGEN), and Others......77
HBV/HCV Therapeutics......78
Table 73: Market Shares of Leading HBV/HCV Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., and Others......78
Table 74: Market Shares of Leading Hepatitis C Virus (HCV), Hepatitis B Virus (HBV) Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Bristol-Myers Squibb Co (BMY), GlaxoSmithKline Plc (GSK), Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK), Vertex Pharmaceuticals, Inc. (VRTX), and Others......79
Infectious Disease Drugs......80
Table 75: Market Shares of Leading Infectious Disease Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, AstraZeneca Plc, Bristol- Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......80
Molecular Chlamydia trachomatis (CT)/Neisseria gonorrhoeae (NG) Equipment......81
Table 76: Market Shares of Leading Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Abbott Laboratories, Becton, Dickinson and Company, Cepheid, Inc., F. Hoffmann-La Roche AG, Hologic Corporation, Qiagen N.V., and Others......81
Molecular Clostridium difficile Equipment......82
Table 77: Market Shares of Leading Molecular Clostridium Difficile Diagnostic Equipment Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Abbott Laboratories, Becton, Dickinson and Company, Cepheid, Inc., Great Basin, Hologic Corporation, Meridian Medical Technologies, Inc., Nanosphere, Inc., Qiagen N.V., Quest Diagnostics, Inc., and Others......82
Table 78: QIAGEN N.V's Sales by Customer Worldwide (2015) - Percentage Market Share Breakdown by Value for Academia, Applied Testing, Molecular Diagnostics, Pharmaceutical......83
Table 79: QIAGEN N.V's Sales by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Americas, Asia-Pacific (APAC), Europe, the Middle East and Africa (EMEA), Rest of World......84
Table 80: QIAGEN N.V's Sales by Segment Worldwide (2015) - Percentage Market Share Breakdown by Value for Consumables and Services, Instruments......85
Table 81: Qiagen N.V.’s Sales by Geographic Region Worldwide (2013-2014) in Percentage for Americas, Europe, The Middle East and Africa and Asia-Pacific & Rest of World......86
Table 82: Qiagen N.V.’s Sales by Product Segment Worldwide (2013-2014) in Percentage for Consumables and Related Revenues and Instrumentation......87